From TPP to CPTPP: why intellectual property matters

Upreti, Pratyush Nath

doi:10.1093/jiplp/jpx216

Cited by 6 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…China (41) and Taiwan (42) have recently adopted the system. Member countries in the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP), such as Brunei, Singapore, New Zealand, Chile, and Vietnam, might introduce the patent linkage system relatively soon, as the agreement requires the linkage system (43). The lessons learned from South Korea demonstrate a rationale for the first generic exclusivity as a valid component of the patent linkage system.…”

Section: Insights Into the Generic Market In South Koreamentioning

confidence: 99%

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

Son

2023

Front. Public Health

View full text Add to dashboard Cite

IntroductionA period of exclusivity for the first generics, as part of the patent linkage system, was established in South Korea to provide an economic incentive for early generic entry. This study describes the dynamics of generic penetration and assesses the first mover market share advantages under the patent linkage system.MethodsPairs of originators and their corresponding generics granted the first generic exclusivity from 2015 to 2020 were identified. We categorized generics into first movers and latecomers, described the penetration curves of generics, and estimated the saturated market share of generics, first movers, and latecomers. Volume-based monthly prescriptions were used to describe the generics’ penetration curves. A logistic growth model was adopted to estimate the saturated market shares of generics.ResultsWe identified 28 pairs of originators and generics, presented penetration curves, and estimated generics market shares. The saturated market share of generics was 30%, and the time to saturation was approximately 33 months. The shapes of penetration varied by nationality, route, and number of generics. The existence of latecomers was associated with the decreased penetration speed over time and decreased market share of generics. However, the first mover market share advantages or latecomers’ disadvantages were consistently observed.ConclusionThe generic uptake in South Korea is delayed, limited, and context-dependent. However, first generics’ market share advantage suggests that a period of exclusivity, as part of the patent linkage system, could provide an economic incentive for early generic entrance.

show abstract

Section: Insights Into the Generic Market In South Koreamentioning

confidence: 99%

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

Son

2023

Front. Public Health

View full text Add to dashboard Cite

show abstract

“…34 Another point worth noting is the inclusion of suspended CPTPP provisions in the RCEP. 35 For example, the suspended CPTPP provision on TPMs is included in the RCEP. 36 The only difference is that the RCEP does not explicitly criminalize the circumvention of TPMs as an offense independent of the existence of copyright infringement.…”

Section: How Is the Rcep Different From The Cptpp?mentioning

confidence: 99%

RCEP IP Chapter: Another TRIPS-Plus Agreement?

Callo-Müller

Upreti

2021

GRUR International

View full text Add to dashboard Cite

fifteen Asian states signed the Regional Comprehensive Economic Partnership (RCEP) 1 that concluded years of negotiations despite uphill geopolitical issues. The agreement is likely to create a populous trade area, boosting intraregional investment and resulting in an important foreign direct investment destination. 2 Generally speaking, the RCEP builds on the free trade agreements (FTAs) signed between RCEP members with a commitment to market access and harmonizes the rules related to trade and investment. It also provides a skeleton for future negotiations based on the existing commitments. According to the recently released summary by the Secretariat, the RCEP aims to establish a 'modern, comprehensive, high-quality, and mutually beneficial economic partnership that will facilitate the expansion of regional trade and investment and contribute to global economic growth and development '. 3 The significance of the RCEP is more geo-political rather than a classical norm-makernorm-taker relationship. No doubt, certain countries such as China will use the RCEP to benefit and strengthen their geo-political influence in the region. This does not

show abstract

“…El día 27 de febrero de 2017 el presidente de Estados Unidos, Donald Trump, firmó una orden ejecutiva para retirar a su país de la negociación del Trans-Pacific Partnership (TPP) (Nath Upreti, 2018). A pesar de que las negociaciones se encontraban concluidas y un texto definitivo había sido consensuado por los países miembros, el retiro de uno de los principales propulsores del tratado levantó preocupación e incertidumbre sobre el futuro de este (Scotti, 2017).…”

Section: Introductionunclassified

Implementación del “linkage farmacéutico” en Chile

Viollier

Pulgar

2022

Rev. derecho (Coquimbo, En línea)

View full text Add to dashboard Cite

El Tratado Integral y Progresista de Asociación Transpacífico es un tratado comercial multilateral que busca dotar a la región de la Cuenca del Pacífico de un marco regulatorio común en distintas materias relacionadas con el comercio. La negociación de sus disposiciones sobre propiedad intelectual resultó particularmente polémica, especialmente aquellas relacionadas con la capacidad de los gobiernos para implementar políticas públicas tendientes a promover el acceso a medicamentos. Este trabajo analiza con detención la institución del vínculo entre registro sanitario y la patente (linkage) en el capítulo de propiedad intelectual del tratado. De esta forma, se busca dilucidar si la implementación del tratado hace necesario que nuestro país modifique su legislación en un sentido que pueda afectar la entrada de medicamentos genéricos al mercado o si, por el contrario, el Tratado Integral y Progresista de Asociación Transpacífico entrega la flexibilidad suficiente para compatibilizar la existencia de mecanismos para el incentivo de la innovación farmacéutica y el derecho de las personas a acceder a medicamentos a precios razonables.

show abstract

From TPP to CPTPP: why intellectual property matters

Cited by 6 publications

References 0 publications

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

Does the first generic exclusivity system provide an economic incentive for early generic entrance under the patent linkage system?

RCEP IP Chapter: Another TRIPS-Plus Agreement?

Implementación del “linkage farmacéutico” en Chile

Contact Info

Product

Resources

About